Excessive centrosome abnormalities without ongoing numerical chromosome instability in a Burkitt's lymphoma

Molecular Cancer

Volumn 2, Issue , 2003, Pages

  Duensing, Stefan ^a   Lee, Benjamin H ^b   Dal Cin, Paola ^b   Münger, Karl ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; PROTEIN P53;

ANEUPLOIDY; ARTICLE; BURKITT LYMPHOMA; CENTROSOME; CHROMOSOME 17; CHROMOSOME 8; CHROMOSOME TRANSLOCATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE OVEREXPRESSION; GENETIC STABILITY; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; KARYOTYPING; LYMPH NODE BIOPSY; NUMERICAL CHROMOSOME ABERRATION; ONCOGENE C MYC; TUMOR SUPPRESSOR GENE; ADULT; CHROMOSOMAL INSTABILITY; GENETICS; MALE; PATHOLOGY;

ADULT; BURKITT LYMPHOMA; CENTROSOME; CHROMOSOMAL INSTABILITY; HUMANS; MALE;

EID: 1242281345     PISSN: 14764598     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-4598-2-30     Document Type: Article

References (29)

1. Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P and Doxsey SJ: Centrosome defects and genetic instability in malignant tumors. Cancer Res 1998, 58:3974-3985.
2. Salisbury JL, Whitehead CM, Lingle WL and Barrett SL: Centrosomes and cancer. Biol Cell 1999, 91:451-460.
3. Kellogg DR, Moritz M and Alberts BM: The centrosome and cellular organization. Annu Rev Biochem 1994, 63:639-674.
4. Hinchcliffe EH and Sluder G: "It takes two to tango": understanding how centrosome duplication is regulated throughout the cell cycle. Genes Dev 2001, 15:1167-1181.
5. Duensing S and Munger K: Centrosome abnormalities, genomic instability and carcinogenic progression. Biochim Biophys Acta 2001, 1471:M81-M88.
6. Nigg EA: Centrosome aberrations: cause or consequence of cancer progression? Nat Rev Cancer 2002, 2:1-11.
7. Lengauer C, Kinzler KW and Vogelstein B: Genetic instabilities in human cancers. Nature 1998, 396:643-649.
8. Klein G: Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men. Cell 1983, 32:311-315.
9. Stearns T, Evans L and Kirschner M: Gamma-tubulin is a highly conserved component of the centrosome. Cell 1991, 65:825-836.
10. Mitelman Database of Chromosome Aberrations in Cancer 2003 [http://cgap.nci.nih.gov/Chromosomes/Mitelman].
11. Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM and Dalla-Favera R: p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1991, 88:5413-5417.
12. Iggo R, Gatter K, Bartek J, Lane D and Harris AL: Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990, 335:675-679.
13. Duensing S and Munger K: Human papillomaviruses and centrosome duplication errors: modeling the origins of genomic instability. Oncogene 2002, 21:6241-6248.
14. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW and Vogelstein B: Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998, 282:1497-1501.
15. Duensing S, Duensing A, Crum CP and Munger K: Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype. Cancer Res 2001, 61:2356-2360.
16. Meraldi P, Honda R and Nigg EA: Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. EMBO J 2002, 21:483-492.
17. Lingle WL, Barrett SL, Negron VC, D'Assoro AB, Boeneman K, Liu W, Whitehead CM, Reynolds C and Salisbury JL: Centrosome amplification drives chromosomal instability in breast tumor development. Proc Natl Acad Sci USA 2002, 99:1978-1983.
18. Duensing S, Lee LY, Duensing A, Basile J, Piboonniyom S, Gonzalez S, Crum CP and Munger K: The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci USA 2000, 97:10002-10007.
19. Duensing S and Münger K: The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res 2002, 62:7075-7082.
20. Sluder G, Thompson EA, Miller FJ, Hayes J and Rieder CL: The checkpoint control for anaphase onset does not monitor excess numbers of spindle poles or bipolar spindle symmetry. J Cell Sci 1997, 110:421-429.
21. Lanni JS and Jacks T: Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol Cell Biol 1998, 18:1055-1064.
22. Lu X, Magrane G, Yin C, Louis DN, Gray J and Van Dyke T: Selective inactivation of p53 facilitates mouse epithelial tumor progression without chromosomal instability. Mol Cell Biol 2001, 21:6017-6030.
23. Bunz F, Fauth C, Speicher MR, Dutriaux A, Sedivy JM, Kinzler KW, Vogelstein B and Lengauer C: Targeted inactivation of p53 in human cells does not result in aneuploidy. Cancer Res 2002, 62:1129-1133.
24. Yin XY, Grove L, Datta NS, Long MW and Prochownik EV: c-Myc overexpression and p53 loss cooperate to promote genomic instability. Oncogene 1999, 18:1177-1184.
25. Brinkley BR: Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends Cell Biol 2001, 11:18-21.
26. Mai S, Fluri M, Siwarski D and Huppi K: Genomic instability in MycER-activated Rat1A-MycER cells. Chromosome Res 1996, 4:365-371.
27. Vafa O, Wade M, Kern S, Beeche M, Pandita TK, Hampton GM and Wahl GM: c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell 2002, 9:1031-1044.
28. Felsher DW and Bishop JM: Transient excess of MYC activity can elicit genomic instability and tumorigenesis. Proc Natl Acad Sci USA 1999, 96:3940-3944.
29. Felsher DW, Zetterberg A, Zhu J, Tlsty T and Bishop JM: Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts. Proc Natl Acad Sci USA 2000, 97:10544-10548.